Albert Bourla, CEO of Pfizer, joins 'Money Movers' to discuss drug pricing, the impact on artificial intelligence on ...

U.S. pharmaceutical companies are stepping up their campaign for higher drug prices in Europe, in some cases threatening to ...

Pfizer is gearing up for a consumer-driven obesity drug market, drawing parallels to the demand surge it experienced with the ...

Facing the loss of exclusivity on key products, Pfizer has pulled forward its lead obesity asset into Phase III and targeted ...

According to reporting from Bloomberg at the J.P. Morgan Healthcare Conference that ended today in San Francisco, ...

Albert Bourla said Pfizer has discussed a fast-pass voucher with the White House during the JPMorgan Healthcare Conference.

US pharma giants seek to dodge Trump’s campaign to lower drug costs . American pharmaceutical corporations are reportedly ...

Pfizer is preparing for a consumer market for obesity drugs on par with the booming business it saw after it launched ...

Big pharma is grappling with new drug pricing deals and roughly $300 billion in potential lost revenue from patent ...

Pharmaceutical companies seek to make up lost revenue after striking deals with Donald Trump to lower costs in US ...